Effectiveness of total hip arthroplasty versus non-surgery on patient-reported hip function at 3 months: a target trial emulation study of patients with osteoarthritis
- PMID: 40223676
- PMCID: PMC11995426
- DOI: 10.2340/17453674.2025.43332
Effectiveness of total hip arthroplasty versus non-surgery on patient-reported hip function at 3 months: a target trial emulation study of patients with osteoarthritis
Abstract
Background and purpose: This study introduces an innovative research design in the field of orthopedics, using a target trial emulation approach. We aimed to assess the causal effects of total hip arthroplasty (THA) compared with nonoperative treatment in reducing patient-reported hip disability at 3 months in patients with osteoarthritis, using real-world data.
Methods: We emulated a target trial using real-world data of 2 Dutch hospitals between April 2020 and January 2022. Patients diagnosed with hip osteoarthritis and eligible for primary THA were included in the study. During the COVID-19 pandemic, THA was often cancelled due to external factors (i.e., limited operating room capacity, or surgeon unavailable due to quarantine rules), resulting in an arbitrary allocation of patients to THA (n = 132) or non-THA (n = 60). We compared changes in hip disability, measured using the Hip disability and Osteoarthritis Outcome Score Physical function Short form (HOOS-PS), between the THA group at 3 months postoperatively and the non-THA group at ≥3 months post waiting-list. Linear regression analysis, adjusting for potential confounders, was used to compare between-group differences.
Results: THA showed preferable outcomes compared with non-THA, indicated by a difference of -33 points (95% confidence interval [CI] -37 to -28) on the HOOS-PS. Patients in the THA group demonstrated a clinically significant improvement in hip function, with a mean change of -27 points (CI -31 to -24), while the control group showed no improvement with a mean change of 7 points (CI 3-11) on the HOOS-PS.
Conclusion: THA significantly improves hip function in osteoarthritis patients, surpassing the outcomes observed in the non-surgery group.
Figures
Similar articles
-
Linking Patient-Reported Outcome Measure Scores to Adverse Event Data to Gain Insight into Overestimation of Postoperative Patient-Reported Outcome Measure Improvement After Total Hip Arthroplasty and Total Knee Arthroplasty Due to Selective Nonresponse.J Arthroplasty. 2025 Jan;40(1):45-52. doi: 10.1016/j.arth.2024.06.064. Epub 2024 Jul 3. J Arthroplasty. 2025. PMID: 38969293
-
What Are the Diagnosis-Specific Thresholds of Minimal Clinically Important Difference and Patient Acceptable Symptom State in Hip Disability and Osteoarthritis Outcome Score After Primary Total Hip Arthroplasty?J Arthroplasty. 2024 Jul;39(7):1783-1788.e2. doi: 10.1016/j.arth.2024.01.051. Epub 2024 Feb 7. J Arthroplasty. 2024. PMID: 38331359
-
Validation of the HOOS, JR: A Short-form Hip Replacement Survey.Clin Orthop Relat Res. 2016 Jun;474(6):1472-82. doi: 10.1007/s11999-016-4718-2. Epub 2016 Feb 29. Clin Orthop Relat Res. 2016. PMID: 26926772 Free PMC article.
-
Outcomes of different bearings in total hip arthroplasty - implant survival, revision causes, and patient-reported outcome.Dan Med J. 2017 Mar;64(3):B5350. Dan Med J. 2017. PMID: 28260601 Review.
-
Discordance Abounds in Minimum Clinically Important Differences in THA: A Systematic Review.Clin Orthop Relat Res. 2023 Apr 1;481(4):702-714. doi: 10.1097/CORR.0000000000002434. Epub 2022 Oct 19. Clin Orthop Relat Res. 2023. PMID: 36398323 Free PMC article.
References
-
- LROI . Dutch Arthroplasty Register (LROI) Annual Report 2024. Available from: https://www.lroi.nl/media/prqogokg/pdf-lroi-report-2024.pdf.
-
- NJR . National Joint Registry (NJR) – 19th Annual Report 2022. Available from: https://wwwnjrcentreorguk/njr-annual-report-2022/ 2022. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous